Galmed Pharma
GLMD----
Galmed Pharma (GLMD)
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Galmed Pharma Analyst Rating
View MoreForecast & Rating
Jun 9, 2026Price forecast
$12.002069.98%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 1 day ago, 06:01 AM
GLMD Q2'26 Earnings: EPS estimate is (0.39) USD
- Global Report · 2 days ago, 04:18 AM
From Nuclear Tech to AI Liquid Cooling: Unpacking Micro-Cap Overhauls
- Price Alert · Jul 17 at 04:52 AM
Pre-market hot trades in US stocks: Galmed Pharma pre-market down 9.09%; United Microelectronics pre-market down 7.09%
- StockTitan · Jul 15 at 10:30 PM
Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol | GLMD Stock News
- benzinga_article · Jul 10 at 04:05 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- PUBT · Jul 8 at 03:17 PM
Galmed Pharmaceuticals buys Colospan in deal valued up to $5.3 million
